Quick Guide for Physicians Based on TIP 49 Download only This manual guides physicians in the use of medications to help patients achieve abstinence from alcohol. It describes how the medications work, whom they benefit, and side effects for three FDA-approved medications: acamprosate, disulfiram, and naltrexone. Publication ID SMA10-4543 Publication Date May 2010 Format Guidelines or Manual More like this TIP Series - Quick Guides Download Quick Guide for Physicians Based on TIP 49 PDF 453.8 KB Find Related Information Audience Prevention Professionals Program Planners, Administrators, & Project Managers Public Health Professionals Population Group People with Alcohol Use or Abuse Problems as Population Group Series TIP Series - Quick Guides You May Also Be Interested In Incorporating Alcohol Pharmacotherapies Into Medical Practice This manual guides counselors in the use of medications to help clients achieve abstinence from alcohol. It describes how the medications work and whom may benefit. It also presents the side effects of three FDA-approved medications: acamprosate, disulfiram, and naltrexone. TIP 48: Managing Depressive Symptoms in Substance Abuse Clients During Early Recovery This guide helps substance use counselors treat clients with symptoms of depression and substance use conditions. Program administrators will learn how to integrate depression treatment into early drug treatment. The guidelines cover screening, assessment, treatment, counseling, cultural competence, and continuing care. TIP 49: Incorporating Alcohol Pharmacotherapies Into Medical Practice This manual provides clinical practice guidelines for using medications in the medication-assisted treatment of alcohol use disorder. It offers guidance on prescribing acamprosate, disulfiram, oral naltrexone, and extended-release injectable naltrexone. The manual also discusses patient management. Access the literature review. Advisory: Prescribing Pharmacotherapies for Patients With Alcohol Use Disorder This Advisory, based on TIP 49, Incorporating Alcohol Pharmacotherapies Into Medical Practice, focuses on medication and related treatment decisions made after screening and assessment for AUD, and medically supervised withdrawal, if necessary. Alcohol consumption should not stop abruptly in those patients who have consumed alcohol regularly over a prolonged period of time. This Advisory is meant as an overview of AUD medications to facilitate abstinence. Growing Older: Providing Integrated Care for An Aging Population This report for clinicians explains approaches to providing integrated care to older adults living with substance use disorder and mental illness. It highlights the importance of assessing patients for cognitive deficits and adapting behavioral interventions to help improve treatment outcomes. TIP 56: Addressing the Specific Behavioral Health Needs of Men This guide addresses specific treatment needs of adult men living with substance use disorders. It reviews gender-specific research and best practices, such as common patterns of substance use among men and specific treatment issues and strategies.